NFKB1 and psoriasis: Systemic inflammation may affect inflammatory signaling pathways in psoriasis patients, such as the nuclear factor-kappa B (NF-κB) signaling pathway, the Toll-like receptor (TLR) signaling pathway, etc. The signalling pathways abnormal activation or inhibition is closely associated with the onset and development of psoriasis.